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1. INTRODUCTION AND REVIEW  
OF LITERATURE 
Untangling the origins of personality has been a popular subject of thought for 
many philosophers in ancient and modern times. The first known personality 
theories are dating back to ancient Greece, where a system of four humours was 
created to explain temperament and health through excess or shortage of four 
bodily fluids – blood, yellow bile, black bile and phlegm. Although this theory 
has been replaced by modern ones, questions about the biological basis of 
personality are still haunting many researchers in psychiatry and behavioural 
sciences. Despite the rapid developments in biotechnology, not much is known 
about the biological and genetic architecture of personality. Contemporarily, 
one of the central issues regards the role of personality traits, together with 
biological and genetic factors, underlying vulnerability to psychiatric disorders, 
e.g. depression and anxiety. In other words, why do some individuals suffer 
from mental illness but others do not? Answering this question would help to 
improve the understanding of human behaviour and would greatly contribute to 
the development of better treatment for psychiatric disorders. 
 
 
1.1. Genetic vulnerability and personality traits  
as risk factors for depression 
1.1.1. Depression 
Depression is a common and seriously impairing disease, carrying the heaviest 
burden of disability among all other mental disorders worldwide (World Health 
Organization, 2008). Large scale epidemiologic studies have suggested that the 
prevalence of major depression can be as high as 7% and 16% for the 12-month 
and lifetime prevalence, respectively (Kessler et al., 2003, Wittchen et al., 
2011). It is noteworthy that the prevalence differs drastically between genders, 
whereas the risk in women is nearly twice as large that in men (Gater et al., 
1998, Kessler et al., 1993, Wittchen, 2011). Depression is characterized by a 
constellation of psychological, behavioural and physical symptoms (Cassano 
and Fava, 2002). These typically include lowered mood, anhedonia, lack of 
interest and motivation, feelings of guilt and worthlessness, reduced 
concentration and disturbances of sleep and appetite (DSM-IV, 1994, Cassano 
and Fava, 2002, ICD-10, 1992). Depression symptoms are to some extent 
overlapping with anxiety disorders and indeed both, depressive and anxiety 
disorders, often coexist in the same patient (Gorman, 1996). Although the first 
episodes of depression often occur in adulthood (Kessler et al., 2007), the 
proportion of early onset in childhood and adolescence is substantial (Fava and 
Kendler, 2000). Full recovery is difficult to achieve as most patients experience 
multiple relapses, and up to 25% of them suffer from a chronic and recurrent 
3
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course (Mueller and Leon, 1996). Considering the deteriorated quality of life for 
the patients, high prevalence of the disorder and the high chance of recurrences, 
depression is a significant contributor to the global burden of disease 
(Gustavsson et al., 2011, Murray and Lopez, 1997, Wittchen, 2011), as 
measured e.g. in Disability-Adjusted Life Years, which express the number of 
years of healthy life lost due to poor health, disability or premature death. 
The etiology and biological mechanisms of the disorder remain poorly 
understood. For decades, the classic monoamine hypothesis has played a 
dominant role in antidepressant drug development. This theory emerged with 
the accidental discovery of the antidepressant properties of monoamine oxidase 
inhibitors (MAOIs), the prototype originally designed for treatment of 
tuberculosis, and tricyclic antidepressants (TCAs), the prototype originally 
designed as an antipsychotic, in the 1950s. The initial monoamine hypothesis 
associated low levels of extracellular monoamine neurotransmitters, serotonin 
(5-HT) and noradrenaline (NA), with depression (Bunney and Davis, 1965, 
Coppen, 1967, Schildkraut, 1965) and further led to the development of modern 
antidepressant drugs, e.g. the selective serotonin reuptake inhibitors (SSRIs). As 
new evidence has emerged about the complexity of pathophysiological mecha-
nisms of depression, this theory has been advanced to more comprehensive 
models of chemical imbalance of the brain (Harro and Oreland, 2001), which 
emphasize, in addition to low levels of all monoamine neurotransmitters, the 
stepwise development of complex alternative changes in brain circuitries as 
depression develops. Further, the deteriorating effects of stress and depression 
on adult neurogenesis in hippocampus, and the ameliorating and reversing 
actions of antidepressants to these effects, have led to the neurogenic hypothesis 
(Duman and Monteggia, 2006, Villanueva, 2013, Warner-Schmidt and Duman, 
2006), and recently complex neural plasticity theories of depression have been 
advanced (Wainwright and Galea, 2013).  
The neurobiological mechanisms of depression are yet to be specified, but 
large scale epidemiological studies have identified several risk factors for 
depression susceptibility. Gender, stressful life events, adverse childhood 
experiences and certain personality traits are standing out with the largest 
evidence base and highest probability for causal link with developing 
depression (Fava and Kendler, 2000).  
 
1.1.2. Vulnerability factors of depression 
The vulnerability – stress model (also known as the diathesis – stress model) 
has often been used to explain the development of psychopathology. In the 
context of depression, vulnerability is a predispositional factor, or factors, 
which makes possible a disordered mental state (Ingram and Luxton, 2005). A 
person’s predisposition combined with stress from life experiences could elicit 
depressive states that individuals without vulnerability do not develop. 
Regarding possible vulnerability factors, substantial amount of existing 
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evidence highlights genetic predisposition and negative emotionality as 
predictors of depression (Kendler et al., 2006, Kendler et al., 1993, Sullivan et 
al., 2000).  
During lifetime, people can experience extreme stress from various life 
events and everyday problems are certainly of different nature for children, 
adolescents and adults. In childhood, the list of potential environmental 
stressors includes parental abuse, neglect, poor parent-child relationships, 
parental discord and divorce, whereas in adulthood, job loss, major health 
problems, marital difficulties and loss of a close personal relationship are all 
linked with a substantial increase in risk for the onset of depression (Fava and 
Kendler, 2000, Kendler et al., 2002). The presence of predispositional vulner-
ability, e.g. genetic and personality factors, increases the risk of developing 
depression when experiencing stress from the environment. However, it is not 
known how exactly the stressors lead from predisposition to depression. 
 
1.1.2.1. Genetic vulnerability 
Depression often runs in families. This notion is supported by a bulk of family 
studies, which have reported up to a 3-fold increased risk for depression in the 
first-degree relatives of probands with depression versus the general population 
(for a review and meta-analysis see Sullivan, 2000). One of the excellent 
methods of ascertaining the environmental and genetic influence are twin 
studies, which enable to “control” for genetic base as monozygotic twins who 
are genetically almost identical can be contrasted to dizygotic twins, who share 
half of their genes. According to some twin studies, the heritability of depres-
sion could be as high as 37% to 50% (Kendler et al., 2001, Kendler and 
Prescott, 1999, McGuffin et al., 1996, Sullivan, 2000). However, estimates of 
gross heritability alone do not give information about the genetic architecture of 
a disorder. This has led researchers to search for gene variants and genetic 
markers responsible for development of depression and associated phenotypes. 
Depression is a heterogeneous and multi-faceted disease with most probably 
a very complex genetic architecture, with many contributing gene variants with 
a small effect size at the population level (Lohoff, 2010). A hypothesis-based 
candidate gene approach is one of the most widely used methods in psychiatric 
genetics, whereas in depression-related research, the candidate gene association 
studies have mainly been led by the classic monoamine hypothesis, but also the 
more recent neural plasticity theories (Levinson, 2006). Several functional 
polymorphisms, especially in the loci encoding the proteins of the 5-HT system, 
have repeatedly been associated with mood disorders or relevant traits, but as a 
rule these findings have not been consistently replicated (for reviews see: 
Levinson, 2006, Lohoff, 2010). Association of a few candidate gene variants 
with depression has survived meta-analysis, but even in these cases the popu-
lation-level effect size is very small. Low statistical power and inadequacies in 
study design, as well as unknown functional relevance of tested single 
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nucleotide polymorphisms (SNPs) are considered among the main limitations of 
these studies (Hattersley and McCarthy, 2005, Lohoff, 2010). 
A limitation of the candidate gene approach itself is that some a priori 
knowledge about the biological mechanisms of investigated trait is required to 
identify possibly relevant genes, which for depression, however, largely still 
remain to be understood. With the rapid developments in biotechnology, it is 
now possible to examine simultaneously the association of millions of common 
gene variants with health-related traits and hence great expectations have arisen 
also regarding unraveling the genetic architecture of depression. Genome-wide 
association studies (GWAS) have gained a lot of attention as a method for 
detecting specific genetic loci related to the etiology of a disease. GWAS are 
hypothesis free and new candidates can be scanned from the entire DNA 
structure. Indeed, some successful GWAS reports have been made (Hindorff et 
al., 2009), but a recent mega-analysis of GWA studies in 18 759 subjects failed 
to identify any specific loci which could play a role in increased (or decreased) 
risk of developing depression (Sullivan et al., 2013). There may be a number of 
reasons for the very limited success with GWAS, as discussed by the authors. 
For example, suboptimal or heterogeneous phenotype, divergent genetic 
architecture of MDD and insufficient power due to too small sample size were 
some of the highlighted issues. With the large-scale scans of hundreds of 
thousands SNPs on complex diseases with probably many small-effect genetic 
variants, there is a high chance of Type I errors which requires stringent 
multiple correction methods (usually Bonferroni correction). However, 
correction for multiple testing comes with a high price, as small genotype 
effects are likely to be considered insignificant (Williams and Haines, 2011). In 
addition, as GWA studies have originally focused on single-locus testing, 
statistical methods for reliable detection of more complex gene × gene (G × G) 
and gene × environment (G × E) interactions are currently under development 
and new approaches have only recently began to emerge (Gauderman et al., 
2013, Hu et al., 2014). Conclusively, in spite of major advantages, the GWAS 
holds several limitations and therefore the hypothesis based candidate gene 
approach remains as a useful method in order to provide new insight in the 
genetic mechanisms underlying depression vulnerability. Any signal picked up 
by GWAS would anyway need further confirmation while probably using the 
candidate gene approach. 
 
1.1.2.2. Personality traits 
Of the personality traits, accumulating evidence has pointed out high 
Neuroticism as a considerable risk factor for developing depression (Clark et 
al., 1994, Enns and Cox, 1997, Kendler, 1993). Neuroticism was first defined 
by H. J. Eysenck as a stable personality trait that is perceived as a continuum 
ranging from the extremely stable to the extremely unstable, poorly integrated 
and neurotic personality type (Eysenck and Prell, 1951). It is also characterized 
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by dysphoria, anxiety, tension and emotional reactivity (e.g. Costa and McCrae, 
1985). Neuroticism is one of the five-factor model (FFM) (i.e. Big Five) 
personality traits, which is a widely accepted set of five broad factors describing 
human personality, consisting of Neuroticism, Extraversion, Openness to 
Experience, Agreeableness and Conscientiousness (Costa and McCrae, 1992, 
Digman, 1990, Goldberg, 1993, John and Srivastava, 1999). The other four Big 
Five domains, apart from Neuroticism, are conceptualized as follows: 
Extraversion – an inclination to feel positive emotions, be energetic, talkative 
and outgoing; Openness to Experience – a tendency to be adventurous, curious, 
inventive and novelty seeking; Agreeableness – a predisposition to be 
compassionate, friendly, cooperative and helpful; Conscientiousness – an 
inclination to self-discipline, efficiency, dutifulness and personal organization 
(Costa and McCrae, 1992). All of the broad dimensions of FFM can be 
decomposed into six lower-order subscales (Goldberg, 1999), which are 
presented in Table 1. 
 
Table 1. Five-factor model broad dimensions and their six subscales according to the 
International Personality Item Pool (IPIP) (Goldberg, 1999). 
Neuroticism Extraversion Openness to 
Experience 
Agree-
ableness 
Conscien-
tiousness 
Anxiety Friendliness Imagination Trust Self-efficacy 
Anger Gregariousness Artistic interests Morality Orderliness 
Depression Assertiveness Emotionality Altruism Dutifulness 
Self-
consciousness
Activity level Adventurousness Cooperation Achievement-
striving 
Immoderation Excitement-
seeking 
Intellect Modesty Self-discipline 
Vulnerability Cheerfulness Liberalism Sympathy Cautiousness 
 
The FFM personality traits emerged from the lexical approach to personality, 
originally formulated by Klages (1932), which states that the most important 
personality characteristics in people’s lives will be encoded into their language, 
and more important traits are more likely to be expressed by a single word 
(Goldberg, 1993, John et al., 1988). Led by this theory, several independent 
researchers tried to identify the core personality factors, and after decades of 
such efforts, it became clear that similar five-factor structures were repeatedly 
found in distinct samples (Digman, 1990, Goldberg, 1993, John and Srivastava, 
1999). These findings were supported by already existing personality constructs 
that had been developed for the personality assessments in clinical context. As 
mentioned above, H. J. Eysenck (1947) was the first to identify Neuroticism, 
4
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but he had also defined Extraversion as another broad personality dimension 
with a great importance in psychopathology, and he provided the Eysenck 
Personality Questionnaire (EPQ) as an assessment instrument (Eysenck, 1998, 
Eysenck and Eysenck, 1975). Merging of the lexical and clinical questionnaire-
based traditions led to the formation of contemporary five-factor model of 
personality (e.g. McCrae and Costa, 1996, McCrae and John, 1992). In addition, 
with the development of the NEO Personality Inventory (NEO-PI) and its 
revised version NEO-PI-R, which measures all five Big Five main domains 
(Costa and McCrae, 1985, Costa and McCrae, 1992), a common standard in the 
personality assessment was created. The NEO-PI-R has gained notable success 
as the FFM-based personality inventories are widely used instruments for 
personality assessments by many researchers worldwide. 
The validity of the FFM, assessed with the NEO-PI-R, has been extensively 
studied and large amount of evidence support the convergent and discriminant 
validity across self, peer and spouse ratings (McCrae and Costa Jr, 1989, 
McCrae and Costa Jr, 2004, Riemann et al., 1997). While the FFM traits are 
considered to be rather stable across adult life, some changes have been 
reported to occur during lifetime (Costa et al., 2000, Costa and McCrae, 1988, 
Roberts and DelVecchio, 2000). Although the FFM personality traits were 
derived from English, the same five-factor structure has been found in other 
languages and cultures (McCrae and Costa Jr, 1997, McCrae and Terracciano, 
2005). These results suggest the universal nature of the FFM, which supports its 
use in investigation of possible underlying genetic factors. Indeed, based on 
twin studies, the heritability of FFM personality traits have been estimated to be 
between 40% to 60% (Jang et al., 1996, Jang et al., 1998), ranging from 0.41 to 
0.49 for Neuroticism, 0.50 to 0.53 for Extraversion, 0.48 to 0.61 for Openness 
to Experience, 0.41 to 0.48 for Agreeableness and 0.44 to 0.49 for Con-
scientiousness (overview in Hare et al., 2012). The remaining variability is 
considered to represent the effects of non-shared environment, but probably also 
includes gene × environment interactions, measurement errors and chance 
factors in development (Bouchard and Loehlin, 2001). Interestingly, shared 
environment has only little or no effect (Bouchard and Loehlin, 2001, Jang, 
1996). 
Given the well-established notion of Neuroticism’s role in depression 
etiology, a common genetic ground would be expected. Indeed, 55% of the 
estimated genetic risk of MDD is found to be shared with Neuroticism 
(Kendler, 1993). But in addition to Neuroticism, other personality traits are also 
associated with greater susceptibility for depression. For example, MDD has 
been predicted by low Extraversion (Enns and Cox, 1997, Fanous et al., 2007) 
and low Conscientiousness (Kendler and Myers, 2010, Kotov et al., 2010, 
Weiss et al., 2009).  
Naturally personality traits also predict other psychiatric conditions and 
health-related behaviours. There is a wide evidence base for high Neuroticism 
to be associated with the development of anxiety disorders (Bienvenu et al., 
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2004, Hettema et al., 2006) and together with low Conscientiousness it seems to 
contribute to substance abuse and dependence (Terracciano and Costa, 2004, 
Terracciano et al., 2008). Certain personality profiles are typical for personality 
disorders (Samuel and Widiger, 2008). Other studies point at the association of 
personality traits with beneficial behavioural endpoints: e.g. on the role of high 
Agreeableness, Conscientiousness and Openness to Experience in educational 
attainment (Poropat, 2009), high Extraversion and Conscientiousness in 
workplace performance (Thoresen et al., 2004) and low Neuroticism but high 
Extraversion and Conscientiousness in regular physical activity (De Moor et al., 
2006, Rhodes and Smith, 2006). 
To be noted, in the literature, negative emotionality is also measured with 
personality dimensions in other instruments, e.g. Harm Avoidance (HA) of the 
Cloninger’s Tridimensional Personality Questionnaire (TPQ) and its newer, 
extended version, Temperament and Character Inventory (TCI) (Cloninger et 
al., 1993). Harm Avoidance is another personality trait often associated with 
depression and similarly to Neuroticism, HA is described as a trait of anxiety 
and pessimism (Cloninger et al., 2006). Indeed, Neuroticism and HA are found 
to be considerably overlapping, but not identical (De Fruyt et al., 2000). 
Differences exist in definitions of major domains by their subscales: 
Neuroticism is formed by six subscales of Anxiety, Anger, Depression, Self-
consciousness, Immoderation and Vulnerability, however Harm Avoidance is 
composed of four subscales of Worry, Fear of Uncertainty, Shyness, and 
Fatigability (Schinka et al., 2004). 
 
 
1.2. Candidate genes for negative emotionality 
A genetic predisposition to vulnerability to stress, together with early exposure 
to stressful life events in critical stages of development, may affect neural 
development and result in a neurobiological phenotype which is reactive to 
stress in a way that may increase the risk of an individual to develop depression 
(Barlow et al., 2014, Lesch, 2004). Given the high probability of common 
genetic factors predisposing to both depressive symptoms and Neuroticism 
(Kendler, 1993), many efforts have been made by researchers to identify 
specific genetic markers responsible for personality traits, however, only few 
candidates have survived the replications. Although large-scale GWA studies 
have initially identified several loci related to personality traits, replication 
attempts so far have not been successful and it has been proven difficult to find 
reliable associations between genetic markers and personality traits (Bae et al., 
2013, de Moor et al., 2012, Terracciano et al., 2011, Terracciano et al., 2010a). 
This, again, has been attributed to the complex genetic architecture of pheno-
typically broad traits, where probably many relevant genetic factors have an 
influence, each of them explaining only a small part of the phenotype variation. 
With the GWAS limitations like reaching sufficient power, and difficulties of 
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detecting genotype interaction effects with other genes and environmental 
factors (for a review see: Montag and Reuter, 2014), the results from candidate 
gene studies could again provide useful insights into the molecular mechanisms 
of depression and related personality traits.  
As discussed above, the search for candidate genes for depression and 
negative emotionality is mainly led by the prevailing theories for depression, 
that is, the chemical imbalance and the neurogenic hypothesis. Therefore genes 
encoding key proteins of the 5-HT and dopamine (DA) systems, and 
neurotrophins have gained much of attention. 
 
1.2.1. Serotonergic system 
Phylogenetically, the serotonergic system is one of the oldest neurotransmitter 
systems in the central nervous system (CNS) (Tecott, 2007). It is involved in the 
regulation of various physiological processes, for example mood, appetite, sleep 
and memory. Serotonin is synthesized from the dietary precursor, amino acid 
tryptophan, which is converted to 5-hydroxytryptophan by the enzyme 
tryptophan hydroxylase (TPH), followed by decarboxylation by aromatic  
L-amino acid decarboxylase (DOPA decarboxylase) to 5-hydroxytryptamine  
(5-HT) (Walther and Bader, 2003). Interestingly, there are two TPH isoforms: 
TPH1 and TPH2, whereas TPH2 is exclusively in the brain and TPH1 is mostly 
found in the periphery (Walther et al., 2003). Serotonergic perikarya are located 
in the brainstem raphe nuclei and innervate the large majority of the CNS 
regions (Dahlström and Fuxe, 1964, Jacobs and Azmitia, 1992). Serotonin is 
released, by exocytosis, into the synaptic cleft between pre- and postsynaptic 
neurons and it activates serotonin receptors, which mediate both excitatory and 
inhibitory neurotransmission (Barnes and Sharp, 1999). The majority of the 
fourteen subtypes of 5-HT receptors are G-protein-coupled receptors, the 
exception being 5-HT3, which is a ligand-gated cation channel. In the synapse, 
the action of 5-HT is throughout the CNS terminated primarily by the 
membrane-bound 5-HT transporter (5-HTT) molecules located on the 
presynaptic neuron, which regulate the synaptic 5-HT levels by re-uptake. 
Blocking some of the 5-HT re-uptake terminals, and hence, increasing the 
synaptic 5-HT levels, is the action mechanism for the most commonly used 
antidepressants, SSRIs (Hyttel, 1994), and also part of the mechanism of action 
of several other antidepressant groups such as the TCAs and SNRIs. 5-HT is 
primarily metabolized by monoamine oxidases (MAO), preferentially by the 
isoenzyme referred to by type A (Shih et al., 1999). MAO catalyses the 
oxidative deamination of 5-HT, which is followed by oxidation to the stable 
metabolite, 5-hydroxyindoleacetic acid (5-HIAA). 
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1.2.1.1. Serotonin in depression and related traits 
The initial version of the monoamine hypothesis proposed the low levels of 
serotonin and noradrenaline in the synaptic clefts to form the basis of depression 
(Bunney and Davis, 1965, Coppen, 1967, Schildkraut, 1965). Because of the 
decades-long emphasis on this hypothesis, the key proteins of the 5-HT system 
have been the most studied amongst all neurotransmitter systems regarding the 
possible association with both depression and related personality traits. Indeed, 
there is no possibility to measure 5-HT release in the brain directly except after 
neurosurgery, and while positron emission tomography would allow indirect 
assessment as does pharmaco-fMRI provide some clues, most of the evidence 
must focus on proteins controlling the levels of 5-HT and mediating its action. 
A large amount of indirect evidence does support the role of 5-HT in 
depression. Historically, much interest was devoted to the lower levels of the  
5-HT metabolite 5-HIAA in cerebrospinal fluid (CSF) of suicide attempters 
with major depression (Mann et al., 1996, Placidi et al., 2001, Traskman et al., 
1981), but this has more recently been attributed more specifically to 
impulsivity associated with self-destructive behaviour (Harro and Oreland, 
2001). In suicide victims, the serotonin transporter availability is decreased in 
post-mortem amygdala and 5-HT2A receptor binding sites are increased in 
prefrontal cortex (PFC) and amygdala (Hrdina et al., 1993). Additionally, in the 
raphe nuclei of depressed suicide victims, increased levels of TPH2 and TPH2 
protein per neuron have been found, which is suggested to be an adaptive 
response to functional serotonin deficiency in projection areas (Bach-Mizrachi 
et al., 2008). Also tryptophan depletion (TD), a paradigm for mood response to 
serotonin depletion achieved by dietary manipulations, induces depressive 
symptoms in some remitted depressive patients and healthy subjects (Smith et 
al., 1997, Young et al., 1985) and reverses antidepressant response (Delgado et 
al., 1999). 
Serotonin transporter is a key protein in the regulation of synaptic 5-HT and 
therefore genetic variations in the 5-HTT gene have gained elevated attention in 
depression-related research. Probably the most studied psychogenetic factor is 
the variable number of tandem repeats (VNTR) polymorphism in the 5-HTT 
gene (SLC6A4) promoter region, the 5-HTTLPR. This polymorphism has a long 
allele with 16 repeats (L) and a short allele with 14 repeats (S), whereas 
carrying the S-allele results in lower transcriptional activity (Heils et al., 1995, 
Lesch et al., 1996). The S-allele can increase the risk for depression (Clarke et 
al., 2010), but these associations mostly emerge when stressful environmental 
factors are taken into account (Caspi et al., 2003, Kaufman et al., 2006, Sjöberg 
et al., 2006). In addition, the S-allele is also associated with suicidal behaviour 
(for a review see: Gonda et al., 2011). Consistently, the S-allele carriers have 
been reported to present heightened amygdala response to stimuli with negative 
affective valence (a review by Munafo et al., 2008), which is often found in 
depressed patients (Suslow et al., 2010). Lesch and colleagues (1996) originally 
found associations between the S-allele and negative emotionality (Lesch, 
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1996), including Neuroticism, but the results in replication studies have been 
inconsistent (see meta-analyses by Munafò et al., 2009, Schinka, 2004, Sen et 
al., 2004). One of the possible confounders is the choice of personality 
measurement instruments. A meta-analysis revealed that the association 
between negative emotionality and the S-allele of 5-HTTLPR has been most 
evident with FFM Neuroticism, in contrast to Eysenck’s Neuroticism or the 
Harm Avoidance of the TCI (Munafò, 2009). 
Tryptophan hydroxylase is the rate-limiting enzyme in the synthesis of 5-HT 
and hence another protein that is universally important for 5-HT-ergic 
neurotransmission throughout the CNS. The brain-specific isoform, TPH2, is 
encoded by the TPH2 gene, which has hence become a candidate gene for a 
wide spectrum of psychiatric conditions (Waider et al., 2010). In mutant mice 
with genetic inactivation of TPH2 function a number of phenotypic changes, 
such as growth retardation, late-onset obesity, enhanced conditioned fear 
response, increased aggression and depression-like behavior have been 
described (Lesch et al., 2013). In humans, a potentially functional single 
nucleotide polymorphism G-703T (rs4570625) in the promoter region of the 
TPH2 gene has been described (Chen et al., 2008, Lin et al., 2007, but see 
Scheuch et al., 2007). Some reports have suggested that the T-allele carriers of 
the TPH2 G-703T variation are more vulnerable to psychiatric disorders related 
to emotional dysregulation, such as personality disorders (Gutknecht et al., 
2007) and depression (Mandelli et al., 2012). According to a recent meta-
analysis of several variations in the TPH2 gene, the G-703T polymorphism had 
the strongest link with major depressive disorder (MDD), the T-allele increasing 
the vulnerability (Gao et al., 2012). This is consistent with the brain imaging 
studies using functional magnetic resonance (fMRI), which have reported 
higher amygdala reactivity in face-processing tasks for T-allele carriers (Brown 
et al., 2005, Canli et al., 2005). In addition, the TPH2 G-703T polymorphism 
has been implicated in other phenotypes that are possibly associated with 
emotional instability, e.g. low executive cognitive control (Baehne et al., 2009, 
Reuter et al., 2007b, Strobel et al., 2007), attention deficit hyperactivity disorder 
(ADHD) (Walitza et al., 2005) and obsessive-compulsive disorder (OCD) 
(Mössner et al., 2006). All this evidence makes TPH2 and this particular 
promoter polymorphism a strong candidate for shaping inter-individual 
differences in anxiety-related personality traits. However, surprisingly little 
direct evidence is available in this regard. Of the few studies published to date, 
Gutknecht and colleagues (2007) found associations of a TPH2 haplotype, 
including the G-703T variation’s G-allele, with increased TPQ/TCI Harm 
Avoidance and FFM Neuroticism scores. Lower HA scores have been reported 
for T/T homozygotes (Reuter et al., 2007a). In a number of studies with 
relatively small sample sizes, however, no association was found with 
Neuroticism (Canli, 2005, Mandelli, 2012, Strobel, 2007).  
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1.2.2. Dopaminergic system 
The best known neural pathways emerging from dopaminergic cells in the 
mammalian brain project either from ventral tegmental area (VTA) 
(mesolimbic/mesocortical pathway) or substantia nigra (nigrostriatal pathway) 
or are intra-regional (tuberoinfundibular pathway in hypothalamus). The 
mesolimbic/mesocortical pathway, which innervates the limbic system and 
frontal cortex, is crucial in behaviour aiming towards natural rewards, such as 
food, sex and social interaction, and also in drug addiction as well as depression 
(Koob and Le Moal, 2001, Nestler and Carlezon Jr, 2006, Wise, 1998).  
Dopamine (DA) is synthesized in the cytoplasm from the amino acid 
tyrosine. The rate-limiting enzyme in dopamine synthesis, tyrosine hydroxylase, 
converts tyrosine to 3,4-dihydroxy-l-phenylalanine (L-DOPA). This is followed 
by the enzymatic activity of DOPA decarboxylase, catalyzing the conversion of 
L-DOPA to dopamine. The effects of DA are exerted through action on five 
dopamine receptor subtypes (D1-D5), which are all G-protein coupled receptors. 
In basal ganglia, the DA signal is terminated by the dopamine transporter 
(DAT), however in the PFC the DA reuptake is mediated by noradrenaline 
transporter (NAT) because of its much higher abundance there. The reuptake is 
followed by the degradation of DA by MAO and catechol-O-methyltransferase 
(COMT) to dihydroxyphenylacetic acid (DOPAC) and homovanillic acid 
(HVA) (Dunlop and Nemeroff, 2007, Molinoff and Axelrod, 1971). 
 
1.2.2.1. Dopamine in depression and related traits 
Dopamine is known by its role in the regulation of motivation (e.g. Depue and 
Collins, 1999, Ikemoto and Panksepp, 1999). As low motivation, anhedonia and 
decreased energy levels are common symptoms in depressive patients, the 
mesolimbic/mesocortical system is proposed to contribute to the patho-
physiology of depression (Nestler and Carlezon Jr, 2006). Also animal models 
of depression imply the role of mesolimbic DA system function, whereas 
chronic antidepressant treatment acts to enhance DA neurotransmission in these 
brain regions (Willner, 1997). In depressed patients, lower levels of CSF HVA 
as compared to controls have been repeatedly reported (Goodwin et al., 1973, 
Mendels et al., 1972, Roy et al., 1989). The possible role of DA system in 
depression is also implicated by the co-occurrence of depression and 
Parkinson’s disease, possibly mediated by dysfunction in mesocortical/ 
prefrontal reward, motivational, and stress-response systems (Cummings, 
1992). The physiological mechanisms underlying reduced dopamine signaling 
in depression are not completely understood, however such a reduction could 
result from either diminished DA release from presynaptic neurons or impaired 
postsynaptic signal transduction, either due to changes in receptor number or 
function and/or altered intracellular signal processing (Dunlop and Nemeroff, 
2007). 
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Catechol-O-methyltransferase is a major enzyme in the metabolic pathway 
of catecholamines that contributes to catabolism of various bioactive molecules 
throughout the organism and has a particularly important role in the prefrontal 
cortex (PFC) for degrading dopamine (Meyer-Lindenberg and Weinberger, 
2006, Tunbridge et al., 2004). COMT is synthesized in two forms from the 
same gene – the soluble COMT-S and membrane-bound MB-COMT, whereas 
the MB-COMT is predominant in the brain (Männistö and Kaakkola, 1999). 
 A functional SNP in the COMT gene results in a methionine (Met) to valine 
(Val) substitution in the position 158 (COMT Val158Met) and impacts the 
activity of COMT enzyme. The Met form of the COMT enzyme is 3–4 fold less 
active and therefore results in increased levels of synaptic dopamine in the PFC 
(Chen et al., 2004a, Weinshilboum et al., 1999). The low activity Met-allele has 
been associated with enhanced cognitive functions. Carrying one or two copies 
of the Met-allele appears to be beneficial in working memory and attentional 
tasks (Barnett et al., 2008, Goldman et al., 2009, Mier et al., 2010, Savitz et al., 
2006). However, the results of studies on the association of this genotype with 
depression and with anxiety disorders are very contradictory indeed. Some 
studies have reported increased corticolimbic responses to emotional stimuli for 
Met-allele carriers (Drabant et al., 2006, Smolka et al., 2005), but others show 
higher amygdala reactivity in Val-allele carriers (Domschke et al., 2012, 
Kempton et al., 2009, Lelli-Chiesa et al., 2011). Moreover, some have found the 
Met-allele to be associated with increased susceptibility to stress, anxiety and 
depression (Eley et al., 2003, Enoch et al., 2003, Stein et al., 2005), but on the 
contrary, others have identified the Val-allele as promoting increased 
susceptibility to these phenotypes (Domschke et al., 2004, Drury et al., 2010, 
Hettema et al., 2008, Massat et al., 2004, McGrath et al., 2004, Rothe et al., 
2006). In addition, a number of reports fail to find any associations with 
depression or anxiety (Bækken et al., 2008, Frisch et al., 1999, Kunugi et al., 
1997, Ohara et al., 1998, Serretti et al., 2003, Wray et al., 2008). 
Similarily, the results on the effect of COMT Val158Met on negative 
emotionality are far from clear. While several studies show no significant 
associations with personality (Henderson et al., 2000, Ishii et al., 2007, Kang et 
al., 2010, Light et al., 2007, Urata et al., 2007), other authors have reported Met 
homozygotes to have lower Extraversion, higher Neuroticism (Eley, 2003, Hoth 
et al., 2006, Reuter and Hennig, 2005, Stein, 2005) and higher Harm Avoidance 
scores (Enoch, 2003, Hashimoto et al., 2007). Interestingly, Harris et al. (2005) 
did not find any effect on Neuroticism or Extraversion, but described a trend 
toward heterozygotes scoring higher on Agreeableness and Conscientiousness 
scales. But subjects with the Val/Val genotype have also been found to score 
higher in Sensation Seeking (Lang et al., 2007), Novelty Seeking (Tsai et al., 
2004b), Harm Avoidance (Kim et al., 2006), negative emotionality scales (Chen 
et al., 2011), and higher in Trait Anger and lower in Anger Control scales (Baud 
et al., 2007). However, most of these genotype effects have been present only in 
female subjects (Baud, 2007, Eley, 2003, Enoch, 2003, Kim, 2006, Lang, 2007, 
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Stein, 2005, Tsai, 2004b), which suggests major gender differences in the 
contribution of the COMT Val158Met genotype and possibly prefrontal 
dopamine to behaviour. 
The large amount of inconsistent findings provides rationale to assume the 
presence of some confounding factors. For example, the samples under 
investigation are very heterogeneous by many aspects and hence may lead to 
contradictory results. To provide further clarification, the effects of COMT 
Val158Met should be studied in large, unbiased and ethnically homogeneous 
samples. 
 
1.2.3. Growth factors, with focus on brain-derived 
neurotrophic factor 
Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin 
family of growth factors, together with three other types of neurotrophins: nerve 
growth factor (NGF), neurotrophin-3 and neurotrophin-4. Their main function is 
to induce and support the differentiation, survival, development and function of 
neurons (Huang and Reichardt, 2001). BDNF is initially produced as a 
precursor molecule proBDNF, which is followed by proteolytic cleaving to 
mature BDNF (Lu, 2003). ProBDNF acts by binding to the receptor p75, 
whereas mature BDNF binds to its receptor tyrosine kinase TrkB (Chao and 
Bothwell, 2002). In the CNS, the role of BDNF is especially prominent in the 
hippocampus and cortex as an enhancer of synaptic plasticity and neuro-
transmission (Croll et al., 1994, Lessmann et al., 1994, Levine et al., 1995, 
Marty et al., 1996, McAllister et al., 1999, Nawa et al., 1993, Poo, 2001). This 
effect is believed to be induced by the neuronal activity-dependent secretion of 
BDNF, a function distinct of other growth factors, which are secreted 
constitutively (Lu, 2003). The activity-dependent secretion of BDNF is crucial 
in hippocampus-dependent memory processes (Egan et al., 2003, Lu and Chow, 
1999). The BDNF and trkB knockout mice exhibit severe deficits in memory 
and learning (Linnarsson et al., 1997, Minichiello et al., 1999). 
   
1.2.3.1. BDNF in depression and related traits 
A large body of evidence shows that stress and depression can lead to neuronal 
atrophy and cell loss in key limbic and associated brain regions implicated in 
depression, including amygdala, PFC and hippocampus, and altered expression 
of neurotrophic factors is found to have a functional significance in these 
processes (Duman and Monteggia, 2006, Manji et al., 2001, Villanueva, 
2013). Brain imaging studies have reported decreased volumes in structures 
such as hippocampus and PFC in depressed patients (Drevets et al., 2008, 
Videbech and Ravnkilde, 2004). In addition, it is widely recognized that stress 
decreases and antidepressant treatment increases hippocampal neurogenesis 
(Warner-Schmidt and Duman, 2006). The importance of BDNF in depression 
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susceptibility has been highlighted, as decreased expression of BDNF 
contributes to the onset of depression and upregulation of BDNF plays a role in 
the actions of antidepressant treatment (Duman and Monteggia, 2006). 
BDNF is coded by the BDNF gene, which includes a SNP Val66Met in the 
5’ pro-domain of the BDNF gene. An amino acid substitution of valine (Val) to 
methionine (Met) at codon 66 affects hippocampal function and memory 
processes (Egan, 2003, Hariri et al., 2003, Pezawas et al., 2004). The Val form 
of BDNF not only reaches the neurites better but also allows for better activity-
dependent secretion of BDNF (Chen et al., 2004b). In a fMRI experiment, the 
Met-allele was associated with stronger amygdala reaction in response to 
emotional stimuli (Montag et al., 2008). In addition, Met-allele has also been 
reported to contribute to the onset of mood disorders (Kaufman, 2006, Kim et 
al., 2007, Verhagen et al., 2010), eating disorders (Ribases et al., 2003, Ribases 
et al., 2004), obsessive-compulsive disorder (Hall et al., 2003) and 
schizophrenia (Frustaci et al., 2008, Hünnerkopf et al., 2007, Sen et al., 2003). 
Studies on any eventual effect of the BDNF Val66Met polymorphism on 
personality traits have resulted in discordant findings. The Met-allele has been 
associated with lower Neuroticism (Frustaci, 2008, Hünnerkopf, 2007, Sen, 
2003) and Extraversion (Itoh et al., 2004, Terracciano et al., 2010b), but others 
reported no association (Tochigi et al., 2006, Tsai et al., 2004a). 
 
1.2.4. Gene × gene interactions 
 Because of the assumption that depression and personality traits have a 
complex genetic base, interactions between variants of different genes that 
encode proteins within neurobiological systems, and proteins of interacting 
systems, are expected. Indeed, the literature provides a large amount of relevant 
reports on genotype interactions, most of them concentrating on polymorphisms 
in genes encoding the proteins of the 5-HT system.  
As probably the most investigated psychogenetic marker, 5-HTTLPR has 
been studied widely regarding possible gene × gene interaction effects on 
depression and related traits. Because 5-HTT and TPH2 are the two key 
proteins for regulation of neurotransmitter levels in the serotonin system, the 
interaction of the functional variants of corresponding genes in behavioural 
regulation is of obvious interest. To our knowledge, no report has been 
published on TPH2 G-703T × 5-HTTLPR interaction effect on personality 
traits. Nevertheless, an additive effect of these two genotypes has been 
described in an emotional picture viewing task using event-related potentials 
(ERPs), and in cognitive-affective tasks with emotional and neutral facial 
expressions and word stimuli by fMRI (Canli et al., 2008; Herrmann et al., 
2007). Carriers of the 5-HTTLPR short variant and the T-allele of 
TPH2 exhibited the greatest degree of neural activation in these tasks. Recently, 
Hahn and colleagues (2013) have reported a positive correlation between 
connectivity of amygdala and hippocampus, and Gray's trait anxiety (BIS) 
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scores in individuals with presumably low synaptic 5-HT level. Low synaptic  
5-HT subjects were defined in this study as TPH2 G-allele homozygotes and  
5-HTTLPR LA-allele homozygotes. Interestingly, in the high 5-HT level group, 
comprising TPH2 T-allele carriers with at least one 5-HTTLPR S or LG-allele, a 
negative association was found instead (Hahn et al., 2013). These findings 
suggest such an interaction between the two genotypes that should have a 
reflection in the style of reaction to the environment, i.e., personality. 
As BDNF promotes the development and function of serotonergic neurons 
(Martinowich and Lu, 2008, Ren-Patterson et al., 2005), interactions of BDNF 
variants with genes affecting the serotonin system should be expected. Indeed, 
some studies have found interaction effects of 5-HTTLPR and BDNF Val66Met 
genotypes on depression and related phenotypes. It has been reported that the 
SLC6A4 gene interacts with BDNF to impact amygdala and anterior cingulate 
cortex volume (Pezawas et al., 2008). Furthermore, an interaction effect of 5-
HTTLPR and BDNF Val66Met and stressful life events has been shown on 
depression in children (Kaufman, 2006) and elders (Kim, 2007). In addition, it 
has been found that the BDNF gene moderates the association of 5-HTTLPR 
with biological stress responses in preschoolers (Dougherty et al., 2009) and the 
effect of 5-HTTLPR on worrying (Bredemeier et al., 2014). Of personality 
traits, Terraciano and colleagues (2010) reported a G × G interaction effect on 
personality: 5-HTTLPR L/L homozygotes scored lower on Neuroticism in the 
presence of BDNF Val variant, whereas they scored higher with the Met-allele.  
Regardless of the large number of studies on gene associations with 
depression-related personality traits, the results have not led to a clear picture. 
There are most likely several reasons for limited replications. One of the main 
issues is the small effect size of the gene variants, which are of course expected 
for complex traits. Moreover, small sample sizes, high ethnic diversity and large 
varieties in the age and health status of the subjects have been highlighted as 
probable confounding factors in candidate gene studies (Chen, 2011). 
Therefore, leaving aside the widely used convenience samples, an ethnically 
homogeneous population representative sample with a longitudinal database 
would contribute greatly to the clarification of the ever-increasing amount of 
contradictory results. Furthermore, such a sample design would enable to assess 
the effect size for general population. 
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2. AIMS OF THE STUDY 
Studies included in this dissertation were intended to explore how do common 
variants of neurotransmission-related genes, often linked to depression and 
negative emotionality, associate with personality traits in a large population 
representative sample. 
 
More specifically, 
‒ Does the BDNF Val66Met polymorphism have any effect on personality 
traits? (Paper I) 
‒ Is COMT Val158Met polymorphism associated with personality traits? 
(Paper II) 
‒ Is TPH2 genotype affecting personality traits? (Paper III) 
‒ Does any eventual association of TPH2 and BDNF genotypes with 
personality interact with the 5-HTTLPR genotype? (Papers I and III)  
‒ Are eventual associations of these functional gene variants with perso-
nality reflected in health-related and personality dependent behaviours, 
such as binge eating (Paper IV), educational attainment (Paper II) and 
depressiveness (Unpublished data) 
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3. MATERIALS AND METHODS 
3.1. The sample 
The sample consisted of the two age cohorts of the European Youth Heart Study 
that was conducted in Estonia in 1998/99 and subsequently incorporated into 
the longitudinal Estonian Children Personality Behaviour and Health Study 
(ECPBHS). It is an ethnically homogeneous sample of Caucasian participants 
and the rationale for sample formation and the procedure has previously been 
described (Harro et al., 2009, Harro et al., 2001, Laas et al., 2014, Tomson et 
al., 2011). Briefly, all schools of Tartu County, Estonia, which agreed to 
participate (54 of the total of 56) were included into the sampling using the 
probability proportional to the number of students of the respective age groups 
in the school, and 25 schools were selected. In 1998/99, all children from grades 
3 (Cohort 1; younger cohort) and 9 (Cohort 2; older cohort) were invited to 
participate and written informed consent was received from 76% of the invited 
subjects and their parents. The total number of subjects in this sampling was 
1176 (583 in Cohort 1, age 9.6 (SD = 0.5) years, 593 in Cohort 2, age of 15.4 
(SD = 0.6) years). The follow-up studies for the younger cohort took place in 
2004 (n = 483, age = 15.3 (SD = 0.5)) and 2007 (n = 453, age = 18.3 (SD = 0.5)); 
for older cohort, the follow-ups were in 2001 (n = 417, age = 18.3 (SD = 0.7)) 
and 2008 (n = 487, age = 24.7 (SD = 0.7)). Permission for the study was 
obtained from the Ethics Review Committee on Human Research of the 
University of Tartu. The study was conducted in accordance with the 
Declaration of Helsinki. 
 
 
3.2. Measurements 
3.2.1. Personality measurements 
The five-factor model personality traits (Papers I, II and III) were measured 
by self-reports with the Estonian version of Revised NEO Personality Inventory 
(NEO-PI-R) (Kallasmaa et al., 2000), EE.PIP-NEO (Mõttus et al., 2006), which 
is a semantically simplified full-length version of NEO-PI-R, Short Five (S5) 
(Konstabel et al., 2011), which is a short inventory of five-factor personality, or 
Estonian Brief Big Five Inventory (EBBFI), which is a short and semantically 
simplified questionnaire (Harro, 2009, Laidra et al., 2006). All scales measure 
each of the FFM personality dimensions (Neuroticism, Extraversion, Openness 
to experience, Agreeableness and Conscientiousness), and their six subscales 
with the exception of EBBFI. All four instruments have been found to provide 
realistic and convergent assessment of personality according to the five-factor 
model (Konstabel, 2011, Laidra, 2006, Mõttus, 2006). Personality data were 
collected at age 15 (younger cohort: EE.PIP-NEO; older cohort: EBBFI), 18 
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(younger cohort: S5; older cohort: NEO-PI-R) and 25 (older cohort: EE.PIP-
NEO). Data were standardized into z-scores for common analysis.  
 
3.2.2. Psychiatric disorders 
The Mini-International Neuropsychiatric Interview (M.I.N.I.5.0.0; Sheehan et 
al., 1998, Estonian version: Shlik et al., 1999) was used to screen for major 
psychiatric disorders at the age 25 (Paper II). Diagnostic assessment was 
carried out by experienced clinical psychologists.  
 
3.2.3. Educational attainment 
At the age 25, the participants were asked to report their current level of 
education, either as 1) primary; 2) secondary; 3) vocational; 4) incomplete 
higher; 5) higher education (Paper II). For the statistical analysis the level of 
education obtained was stratified in three levels: 1) primary; 2) secondary and 
vocational; 3) higher (including incomplete higher) education. 
 
3.2.4. Socioeconomic status 
The participants were asked to report their monthly income, as well as the 
monthly income of their household (Paper II). Also they were asked to assess 
the economic status of their household on a 5-point scale, ranging: 1 – we have 
huge difficulties in coping ….. 5 – we are coping very well. To assess the 
perceived socioeconomic status the participants were asked to rate themselves 
on a 10-step scale ranging: 1 – I feel repelled from society ……10 – I feel I 
belong to the most influential part of society. 
 
3.2.5. Body weight regulation 
Participants were asked whether they have tried to regulate their body weight 
(1. Yes, I have tried to increase my body weight, 2. No, I don’t think it’s 
necessary to regulate my body weight, 3. Yes, I have tried to decrease my body 
weight), and indicate which methods of the following they had been using: 
dieting (avoiding high-fat and/or high carbohydrate food), restriction of meal 
sizes, training, reduction in meal frequency, starvation (no food intake for at 
least 24 h), or any other methods not mentioned in the questionnaire (Paper 
IV). 
 
3.2.6. Eating behaviour and attitudes 
Two subscales of Eating Disorders Inventory-2 – Drive for Thinness and 
Bulimia – were used to assess eating behaviour and attitudes (EDI-2; Garner, 
1991; Estonian versioon: Podar et al., 1999) (Paper IV). The Drive for 
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Thinness subscale measures concern and preoccupation with dieting and weight 
gain, the Bulimia subscale measures the tendency to think about and engage in 
episodes of binge eating. These subscales have been shown to be most directly 
related to eating-disordered behaviour (Hurley et al., 1990). 
 
3.2.7. Depressiveness 
Depressiveness was assessed during the second and third study wave using the 
self-report format of the Montgomery – Åsberg Depression Rating Scale 
(MÅDRS; Montgomery and Åsberg, 1979) or Beck Depression Inventory (BDI; 
Beck et al., 1961) (Unpublished data). Subjects of the younger cohort filled 
BDI at age 15 and MÅDRS at age 18; and subjects of the older cohort filled 
MÅDRS at ages 18 and 25. 
 
3.2.8. Anxiety 
Anxiety levels were measured with the Spielberger State Trait Anxiety 
Inventory (STAI; Spielberger, 1983) (Unpublished data). Anxiety data were 
collected from the younger cohort at ages 15 and 18; and from the older cohort 
at age 25. 
 
3.2.9. Genotyping 
3.2.9.1. 5-HTTLPR 
DNA was extracted from venous blood with QIAamp DNA Midi kit (Qiagen, 
Hilden, Germany). The alleles at the 5-HTTLPR locus were amplified following 
protocols described by Paaver et. al (2007) (Paper I) and Tomson et al. (2011) 
(Paper III).  
 
In Paper I, the alleles at the 5-HTTLPR locus were amplified from genomic 
DNA using PCR. The polymorphic region was amplified using the primers 5-
HTTLPR-F: CAA CCT CCC AGC AAC TCC CTG TA, 5-HTTLPR-R: GAG 
GGA CTG AGC TGG ACA ACC AC, where the forward primer was 
fluorescently labeled with a 5′-FAM. Reagents and conditions for the PCR 
reaction were: 1× PCR buffer (Perkin Elmer, AmpliTaq Gold buffer II), 200 μM 
dNTP with 50% of dGTP replaced with 7 deaza-dGTP, 2 mM MgCl2, 1 μM of 
each primer, 1 U Taq polymerase (Perkin Elmer, AmpliTaq Gold) and 20 ng 
genomic DNA, in a total reaction volume of 10 μL. The reaction started with 
10 min at 95°C, followed by 40 cycles with 30 s at 95°C, 30 s at 59°C, 30 s at 
72°C and ended with 7 min at 72°C. PCR products were then run on an ABI 
PRISM 3700 DNA analyzer (Applied Biosystems, USA.) and scored using the 
software GeneMarker 1.5 (SoftGenetics, U.S.A.). All genotypes were manually 
checked on chromatograms to detect inconsistencies and where needed, 
amplified and scored a second time. 
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In Paper III, the 5-HTTLPR polymorphic region was amplified using the 
primers 5-HTTLPR-F: 5′-6FAM-ATG CCA GCA CCT AAC CCC TAA TGT-3′ 
and 5-HTTLPR-R: 5′-GGA CCG CAA GGT GGG CGG GA-3′. PCR reaction 
components and final concentration were as follows: 1 x of 5x HotFirepol 
BLEND with BSA 2.5 mM MgCl2 (Solis Biodyne); 5% of DMSO; 1 x of 10x 
Solution S (Solis Biodyne); 380 μM each of the forward and reverse primers; 
10–50 ng of template DNA. The amplification was conducted in a total volume 
of 20 μl. The touchdown PCR cycles were used as by Anchordoquy et al. 
(2003). The electrophoresis was made on ABI PRISM 3130XL genetic analyser 
(Applied Biosystems, USA) and the components used were: 1 μl PCR product, 
10 μl Hi-Di formamide, 0.25 μl Liz 500 size standard. Genotypes were 
generated using ABI Gene-Mapper V 4.0 software.  
 
3.2.9.2. BDNF Val66Met 
BDNF Val66Met (SNP rs6265) genotyping was carried out by restriction 
analysis, and to eliminate any chances of false positive or false negative results, 
extra sequencing reactions were performed on 23% of the sample (Papers I and 
IV). No inconsistencies between the two methods occurred. 
Amplification reactions were performed in a total volume of 20 µl with  
10–50 ng of template DNA, using thermal cycler „Biometra UNO II”. PCR 
reaction components and final concentration were as follows: 1:10 tartrazine 
buffer (750 mM Tris HCl, pH 8.8, 200 mM (NH)2SO4, 0.1% Triton x 100, 5% 
Ficoll 400, 10 mM tartrazine); 1.9 mM MgCl2; 0.1 mM dNTP; 0.5 pmol/µl 
primer F 5’-ACT CTG GAG AGC GTG AAT-3’; 0.5 pmol/µl primer R 5’-ATA 
CTG TCA CAC ACG CTC-3’; 1.5U Taq DNA polymerase (FIREPol). To 
determine the possible contamination, a negative control was added to every 
experiment. The PCR cycling conditions consisted of an initial denaturation of 
2 min at 95°C, followed by 37 cycles of 96°C for 20 s, 50°C for 15 s, 72°C for 
40 s, and final extension 72°C for 6 min. PCR products were visualized on 2% 
agarose gel electrophoresis with ethidium bromide. 
 
3.2.9.3. COMT Val158Met 
COMT Val158Met polymorphism (rs4680) genotyping reactions were per-
formed in a total volume of 20 μl with 10–50 ng of template DNA. The real-
time polymerase chain reaction (RT-PCR) was performed with primers and 
fluorescent probes obtained from Applied Biosystems (Foster City, CA, USA) 
Custom TaqMan SNP Genotyping Assays. RT-PCR reaction components and 
final concentrations were as follows: 1:5 5xHOT FIREPol Probe qPCR Mix 
Plus (ROX) (SolisBiodyne) and 1:20 80xTaqMan Primers Probe (F 5’ –
CCCAGCGGATGGTGGAT –3’; R 5’ –CAGGCATGCACACCTTGTC –3’; 
Reporter 1 –TTCGCTGGCATGAAG (VIC); Reporter 2 –TCGCTGGCGTGAAG 
(FAM)). Reactions were performed on the ABI 7500 Real-Time PCR system 
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(Applied Biosystems, USA) and the amplification procedure consisted of an 
initial denaturation step at 95°C for 15 min and 40 cycles of 95°C for 15 s and 
60°C for 1 min. All reactions were carried out in duplicate and extra negative 
controls were added to each reaction plate.  
 
3.2.9.4. TPH2 G-703T 
Genotyping for TPH2 G-703T (rs4570625) was performed on the Applied 
Biosystems ViiA™ 7 Real-Time PCR System using TaqMan® Pre-Designed 
SNP Genotyping Assay and Solis BioDyne 5x HOT FIREPol® Probe qPCR 
Mix Plus (ROX). 
 
3.3. Statistical analysis 
Owing to the small number of BDNF Val66Met Met homozygotes in our 
sample (n=19), the genotype was divided into two groups – Val homozygotes in 
one group (Val) and Met-allele carriers in another group (Met). All other 
genotypes (5-HTTLPR, COMT Val158Met, TPH2 G-703T) were grouped 
based on their allelic variances. All genotype frequencies were found to be 
consistent with the Hardy-Weinberg equilibrium. 
For statistical analyses, one-way and two-way analysis of variance or 
covariance (ANOVA or ANCOVA) were used to test the main effects on 
personality traits of all polymorphisms under investigation, and gene × gene 
interactions with the 5-HTTLPR polymorphism or interaction with sex. 
ANOVA was also used to test the associations between the test scores of eating 
behaviour and the BDNF Val66Met genotype. Mixed linear model analysis was 
carried out to test the interactions with age. Fisher’s LSD was used for post-hoc 
comparisons and contrasts were calculated for significant model effects. To test 
for main effects of COMT Val158Met on education and psychiatric disorders 
the Pearson chi-square test was used. Mixed linear model analysis was carried 
out using the SPSS Statistics version 19. All other statistical analyses were 
carried out with STATISTICA 7.0. 
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4. RESULTS AND DISCUSSION 
4.1. Associations of depression- and anxiety-related 
gene polymorphisms with personality  
4.1.1. BDNF Val66Met polymorphism and  
personality traits (Paper I) 
BDNF Val66Met polymorphisms was associated with Conscientiousness, 
whereas the Met-allele carriers scored significantly lower than Val-homozy-
gotes (F(1,807) = 4.32, p = 0.038). The Met-allele carriers thus tend to be less 
organized, determined and cautious, but also more impulsive and spontaneous 
than the Val homozygotes. The deteriorating effect of the Met-allele was most 
evident with C1: Self-Efficacy and C2: Orderliness facets (Figure 1), which 
indicates that Met-allele carriers may have lower level of accomplishment, 
effectiveness and organization, compared to their peers. 
 
Figure 1. Personality profiles for BDNF Val homozygotes and Met-allele carriers.  
* – significant differences between Val homozygotes and Met-allele carriers. 
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Besides high Neuroticism, low Conscientiousness has repeatedly been found to 
increase depression risk (Kendler and Myers, 2010, Kotov, 2010). Health-
related effects of Conscientiousness may arise from its influence on behaviours 
that may lead to poor health, e.g. substance use (Terracciano, 2008) or lack of 
physical exercise (Rhodes and Smith, 2006). Conscientiousness, as a trait for 
high orderliness, efficiency and self-discipline, is also related to prospective 
memory (Uttl et al., 2013). Indeed, to be conscientious, one has to be able to 
make and follow plans, which requires good memory performance. Given the 
importance of BDNF in memory processes (e.g. Egan, 2003), our findings may 
indicate that fundamental brain functions (i.e., personality and memory) have 
some overlaps in their genetic architecture. On the other hand, memory can 
contribute to the perception of Conscientiousness through remembering certain 
behaviours from the past, when completing the personality questionnaires.  
Several previous studies have reported the Met-allele carriers to score lower 
on Neuroticism or Extraversion scales, however no association has previously 
been observed regarding Conscientiousness. There may be a number of reasons 
for this. The principles of sample formation may influence the variability of 
personality dimensions in the sample. The study of Sen and colleagues (Sen, 
2003) that originally demonstrated the effect of Val66Met polymorphism on 
Neuroticism did not reveal any genotype effect on other FFM personality 
dimensions, including Conscientiousness. The sample they used was recruited 
from a blood pressure monitoring program targeted on families, and thus 
certainly not representative of the whole population. It is likely that their sample 
was relatively high in Conscientiousness, because this personality trait would 
facilitate family life and involvement in a long-term program targeted at health 
issues. In a small Japanese study which was on a sample of staff and students of 
a university, the results in fact reflected a non-significant trend towards lower 
Conscientiousness in Met carriers (Itoh, 2004). However, several studies have 
shown that high Conscientiousness can predict academic success (Noftle and 
Robins, 2007, O’Connor and Paunonen, 2007, Vedel, 2014). High school 
students are more conscientious and therefore more successful in their studies 
than their peers. When the sample is composed entirely out of college and 
university students, then it is already significantly biased towards higher 
Conscientiousness. Hence the dispersion of this trait might be too small, leading 
to false negative results. 
The data of this study were collected from the second study wave, where the 
average age for the younger cohort was 15 and older cohort 18 years. As of 
writing this dissertation we have collected additional data from the third study 
wave, where the average age was 18 and 25 years for younger and older cohort, 
respectively, and this allows us to pool data of both cohorts age-wise at age 18. 
We failed to detect any significant BDNF Val66Met main effects on Con-
scientiousness, however, a tendency for a gene × sex interaction emerged  
(F(1, 821) = 3.70, p = 0.055). Male Met-allele carriers expressed a strong trend 
for lower Conscientiousness, compared to all other subjects. These results 
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support previous findings on gender specific effects of the BDNF Val66Met 
polymorphism on depression, whereas male Met-allele carriers show increased 
risk (for a meta-analysis see Verhagen, 2010). However, as the mean age of 
subjects included in the meta-analysis were higher compared to our sample 
(50.6 years for cases and 47.6 years for controls), this issue should be addressed 
again in the future in our longitudinal sample to assess possible age-dependent 
effects. 
 
4.1.2. COMT Val158Met genotype and  
personality traits (Paper II) 
The importance of dopamine in behaviour and psychopathology gives reason to 
examine the possible role of COMT Val158Met polymorphism on personality 
traits and their development on a large population representative sample, which 
we addressed in Paper II. We used the data of all three study waves on the 
older cohort of the ECPBHS sample, the participants having respectively been 
15, 18 and 25 years old. Mixed linear modeling of these longitudinal dataset of 
general population revealed that in the five-factor model, COMT Val158Met 
does have an effect on personality traits, particularly on Neuroticism. 
Interestingly these effects became manifest by the time of young adulthood, 
observed at the present study at age 25, by which age women with the Val/Val 
genotype had developed higher Neuroticism (Figure 2). This made it irrational 
to examine the genotype effect on personality in the younger cohort of the 
ECPBHS until they will have been participated in the scheduled data collection 
wave at age 25. In addition, we found the effect of COMT genotype on 
Conscientiousness to increase with age. By the age of 25 female heterozygotes 
scored higher than both homozygote groups on the Conscientiousness scale. 
There was a tendency of low Conscientiousness being more evident in males, 
whereas high Neuroticism is manifested more in females. In population-
representative samples, Neuroticism and Conscientiousness correlate nega-
tively, and in the future, it seems worthwhile to examine whether subgroups of 
males and females have, dependent on COMT genotype, different perception of 
aspects of these traits. 
Reported associations of gene variants affecting the activity of the dopamine 
system with personality traits have been inconsistent (Ebstein, 2006, Reif and 
Lesch, 2003) and so our findings also stand in contrast to several of the previous 
results regarding COMT Val158Met effect on personality traits (Eley, 2003, 
Hoth, 2006, Reuter and Hennig, 2005, Stein, 2005). As noted by Chen and 
colleagues (Chen, 2011), some of the reasons for inconsistent results in the 
studies with COMT genotype may be due to small sample sizes, high ethnic 
diversity and different age groups. Age-dependency of effects of functional 
gene variants on personality has previously been reported (Harro and Kiive, 
2011, Harro, 2009, Laas, 2014). A twofold increase in COMT enzyme activity 
has been shown from post-birth to adulthood (Tunbridge et al., 2007) and this 
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may have an effect on the development of personality traits. Therefore, the 
developmental stage should be considered while comparing different studies on 
the association of genes and personality, and in elucidating the mediating 
neurobiological mechanisms. 
 
 
Of other personality traits, Conscientiousness, mostly associated with being 
organized, responsible and dependable, is the best predictor of mental health. 
Our results indicate that in addition to the increased Neuroticism by the age 25, 
Val homozygotes scored the lowest on Conscientiousness scale. Although 
Neuroticism is a strong predictor of stress and dysphoria the correlations 
between Neuroticism and different anxiety disorders vary (Watson et al., 2005), 
thus it would be reasonable to explore the association of COMT genotype in 
relation to different types of anxiety disorders with adequate sample size. Since 
the manifestation of mental disorders, including anxiety disorders and 
depression, are moderated by adverse life events and social support, it would be 
worthwhile to address these aspects in relation to COMT genotype as well. 
Nevertheless, excessive speculation should be avoided at this stage, as the 
results of this study should be considered exploratory because of the limitation 
of not correcting for multiple testing that makes replications on other samples 
mandatory before major conclusions can be drawn.  
 
 
 
 
 
 
Figure 2. Personality profiles by genotype and gender at age 25; z-scores. *: p < 0.05 
vs. all comparison groups. N: Neuroticism; E: Extraversion; O: Openness to experience; 
A: Agreeableness; C: Conscientiousness. 
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4.1.3. TPH2 G-703T genotype and  
personality traits (Paper III) 
Variations in the tryptophan hydroxylase gene, encoding for the rate-limiting 
enzyme in the 5-HT synthesis, may modulate the 5-HT system and therefore 
also behaviour. Hence, in Paper III, we aimed to study the effects of TPH2  
G-703T polymorphism on personality traits and their development in this large 
population-representative sample. We pooled the data of the younger and older 
cohorts age-wise, at age 15 (n = 742) and 18 (n = 834). We found that, indeed, 
the TPH2 G-703T genotype is associated with personality traits of the five-
factor model. At age 15, subjects with the T/T genotype scored considerably 
lower on Neuroticism and higher on Conscientiousness scale. Three years later, 
by the age of 18, the T/T homozygotes again scored the highest on Con-
scientiousness and also Extraversion, however the effect on Neuroticism was no 
longer significant (Figure 3). Indeed, the mixed linear model analysis revealed 
the age-dependent genotype effect on Neuroticism, whereas at age 15 the T/T 
homozygotes scored significantly higher compared to G-allele carriers, but by 
the age 18 they were more similar to other groups.  
 
 Our results are consistent with previous findings on higher negative emotio-
nality in the G/G genotype that were based on Harm Avoidance scores (Reuter, 
2007a). However, none of the previous studies had found G-703T main effect 
on Neuroticism, the negative emotionality scale of the FFM. Gutknecht and 
colleagues (2007) reported a haplotype association of TPH2 G-703T with TPQ 
Harm Avoidance and FFM Neuroticism, in a sample of university students  
(n = 336). Strobel et al. (2007) have described a tendency of G/G homozygotes 
 
Figure 3. TPH2 G-703T genotype and personality profiles at age 15 and 18. Data are 
presented as z-scores. * – p < 0.05 vs. all comparison groups; ** – p < 0.001 vs. G/T; 
*** – p = 0.0001 vs. G/T; # – p < 0.001 vs. G/G (Fisher’s LSD). N: Neuroticism;  
E: Extraversion; O: Openness to experience; A: Agreeableness; C: Conscientiousness. 
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scoring higher on Neuroticism, however, as pointed out by the authors, the 
sample size was small (n = 78). In a number of studies the T/T and G/T 
genotype groups have been combined and contrasted to G/G homozygotes, due 
to the small number of T/T homozygotes (e.g. Canli, 2005, Hahn et al., 2013, 
Strobel, 2007). However, some evidence has suggested that subjects with the 
T/T genotype could differ from the other genotype groups, e.g. they scored 
lower on HA scale (Reuter, 2007a), and this is consistent with the present data 
in a large population-representative sample. Interestingly, the G/T and G/G 
subjects had a very similar personality profile. 
Because of the broad and comprehensive nature of the main domains, 
analyses on the facet level may lead to better prediction of behaviour (Paunonen 
and Ashton, 2001). We therefore further examined the TPH2 G-703T effect on 
the subscales of Conscientiousness at age 18, when the association was the 
strongest. Amongst the six subscales of Conscientiousness domain our results 
show the strongest genotype association with Orderliness and Self-Discipline, 
and the weakest with Cautiousness. Speculatively, this may have implications to 
a potential link between serotonergic system and locus of control. The present 
study also suggests that the TPH2 G-703T genotype association with 
personality should not be expected in studies with small number of participants 
unless the sample is biased. 
 
4.1.4. Moderation by the 5-HTTLPR genotype  
of the gene × personality associations (Papers I and III) 
4.1.4.1. BDNF Val66Met × 5-HTTLPR interaction effect  
on personality traits 
Considering the possible epistatic effects between the SLC6A4 and BDNF genes 
(Kim, 2007, Pezawas, 2008, Terracciano, 2010b), exploration of interaction effect 
of the functional 5-HTTLPR × BDNF Val66Met polymorphisms on personality 
traits is of obvious interest. This issue was addressed in Paper I, where we used 
the data of both cohorts from the second study wave. At the time of assessment, 
participants in the younger cohort were 15 and older cohort 18 years old.  
Indeed, our results showed a gene × gene interaction on personality traits. 
BDNF Met-allele carriers with the 5-HTTLPR S/S genotype scored lower on 
Conscientiousness than their peers (Figure 4). The effect of the Val66Met 
genotype on Conscientiousness mainly rested on its large effect in the S/S 
group. This effect was significant in Conscientiousness facets C1: Self-Efficacy 
and C4: Achievement Striving. Both of these facets are related to goal-
orientation, accomplishment and achievement, and appear to be inferior in 
participants with this allelic combination. Additionally we found that BDNF 
Val-allele homozygotes with 5-HTTLPR S-allele carriers score lower in 
Openness to Experience facet O6: Liberalism. People with this allelic combi-
nation may thus prefer more traditional values. 
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Previous reports on 5-HTTLPR × BDNF Val66Met interactions have resulted 
with mixed findings. Pezawas and colleagues (2008) demonstrated an 
interaction effect on the volume reduction of anterior cingulate cortex, 
suggesting a protective effect of BDNF Met-allele in S-allele carriers. Others 
have identified 5-HTTLPR S/S genotype together with a BDNF Met-allele as a 
risk genotype for depression, but only in interaction with environmental factors 
(Kaufman, 2006, Kim, 2007). However, to our knowledge the only study 
reporting an 5-HTTLPR and BDNF interaction on personality traits in a large 
sample found the 5-HTTLPR L/L homozygotes to score lower on Neuroticism 
in the presence of two BDNF Val-alleles, whereas Met-allele carriers scored 
higher (Terracciano, 2010b). This effect technically differs from our results, 
where we demonstrated the lowest Conscientiousness scores in S/S homozy-
gotes with at least one Met-allele present, but it should be born in mind that 
Neuroticism and Conscientiousness are in negative correlation in population-
derived samples. 
 
 
Figure 4. Significant interactions of 5-HTTLPR and BDNF Val66Met polymorphisms 
on personality traits and their facets. Pairwise comparisons made with Fisher’s LSD 
test. * – p < 0.05 vs all other groups. ** – p < 0.05 between two groups. 
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4.1.4.2. The interaction effect of TPH2 G-703T and 5-HTTLPR 
polymorphisms on personality traits 
The two principal proteins in the serotonergic neurotransmission, 5-HTT and 
TPH2 are both involved in the regulation of neurotransmitter levels available 
for release in the brain. Therefore the interaction of functional polymorphisms 
in genes encoding these proteins on behavioural measures, e.g. personality, can 
be expected. In Paper III, we aimed to study the possible G × G interaction 
effect on personality traits at age 15 and 18. We used data of both birth cohorts 
of ECPBHS with age-wise combined z-scores. An interaction effect on 
Conscientiousness at age 18 (F(4, 816) = 2.99, p = 0.018) was found. Indeed, 
the association of TPH2 G-703T genotype with Conscientiousness was entirely 
dependent on the 5-HTTLPR genotype: the TPH2 effect was evident only in  
5-HTTLPR S-allele carriers (Figure 5). 
  
To the best of our knowledge there has been no previous report regarding TPH2 
× 5-HTTLPR interaction on FFM personality traits. This may well suggest that 
studies on smaller or less representative samples have missed the effect of the 
minority T-allele. Nevertheless, our findings are partially in accordance with the 
results of EEG and fMRI studies of emotional picture viewing and cognitive 
affective tasks, where carriers of the combination of TPH2 T-allele and 5-
HTTLPR short variant exhibited the greatest degree of neural activation in these 
tasks (Canli et al., 2008; Herrmann et al., 2007). Obviously, given the 
significantly smaller sample sizes in brain imaging studies, subjects with the 
 
 
Figure 5. TPH2 G-703T × 5-HTTLPR interaction effect on Conscientiousness at age 
18. Data are expressed as z-scores +/– SEM. * – p < 0.01 vs. all TPH2 G-allele carriers; 
** – p < 0.01 vs. all TPH2 G-allele carriers and all 5-HTTLPR L/L genotype groups 
(Fisher’s LSD). 
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genotype combination of T/T-homozygotes and the S-allele would be rare, but 
measurement of the endophenotypes is closer to the gene than self-reported 
personality and hence expected to be more sensitive, even detecting the 
difference with a single T-allele of the TPH2. Additionally, Hahn and 
colleagues (2013) have reported a positive correlation between connectivity of 
amygdala and hippocampus, and Gray’s trait anxiety (BIS) scores in individuals 
with the combination of TPH2 G/G and 5-HTTLPR LA/LA genotypes. 
Interestingly, in the TPH2 T-allele carriers with at least one 5-HTTLPR S or 
LG-allele, a negative association was found instead (Hahn, 2013). Together with 
our findings on personality traits, it seems plausible that such an interaction 
between the two genotypes reflect a certain style of reaction to environment and 
putative changes in serotonergic neurotransmission may impact fundamental 
phenotypes, i.e. personality. 
But in addition to G × G interactions on personality, also G × E interactions 
may play a pivotal role. Based on twin studies, the genetic component in 
personality is substantial, whereas shared environmental effects have little, if 
any, effect on personality traits (Bouchard and Loehelin, 2001). However, 
unique non-shared environmental effects seem to have more pronounced 
impact, but this in essence probably comprises several residual causes, e.g. 
measurement errors, chance and G × E interactions (Bouchard and Loehelin, 
2001). Indeed, early environmental stressors, e.g. childhood adversities and 
trauma, may influence children’s cognitive styles and moderate risk for a 
persistent state of negative emotionality, which, in turn, increase the probability 
of developing anxiety and mood disorders (Barlow, 2014). Furthermore, the 
combination of genetic predisposition and early life stress may sensitize key 
circuits within the brain, e.g. the hypothalamic–pituitary–adrenal (HPA) axis, in 
response to acute stress, leading to altered stress reactivity (Barlow, 2014). 
Therefore, the possible impact of genotype and stressful life events interaction 
effects on personality traits should be addressed in the future. 
 
 
4.2. Associations of these functional gene  
variants with personality reflected in health-related 
and personality dependent behavior  
(Papers II, IV and unpublished data) 
4.2.1. The impact of BDNF Val66Met genotype on food 
restriction in body weight regulation (Paper IV) 
Eating disorders represent a group of mental illnesses characterized by 
abnormal eating behaviour, which harms individual’s physical and mental 
health. Brain-derived neurotrophic factor has been regarded as a possible 
candidate molecule associated with the etiology of eating disorders. BDNF is 
widely distributed in the regions associated with regulation of eating behaviour 
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and energy intake, such as hypothalamic nuclei (Kernie et al., 2000). Evidence 
from the animal studies supports the role of BDNF in the modulation of 5-HT 
turnover and appetite (Lyons et al., 1999, Pelleymounter et al., 1995). In 
addition,hyperphagia and obesity are present in conditional mutant mice with 
complete deletion of BDNF (Rios et al., 2001). In humans, the BDNF Met-
allele carriers are reported to have higher body mass index and increased 
obesity risk (Beckers et al., 2008). Furthermore, associations with disordered 
eating are supported by a meta-analysis, which concluded that Met-allele 
carriers have increased risk of developing an eating disorder compared with the 
Val/Val homozygotes (Gratacos et al., 2007), however, a more recent meta-
analysis failed to detect associations between BDNF Val66Met and, 
specifically, anorexia nervosa (Brandys et al., 2013). 
In Paper IV, we aimed to study the BDNF Val66Met effect on eating 
behaviour and body weight regulation in both birth cohorts of our study. The 
data were collected during the second study wave, when the participants of 
younger and older cohorts were 15 and 18 years old, respectively.  
We found an interaction effect between the genotype and food restriction on 
scores of Bulimia among girls. More specifically, an interaction was found between 
Val66Met genotype and the reduction of meal frequency (F(1,386) = 5.70,  
p = 0.02) and between Val66Met genotype and starvation (F(1,385) = 5.52,  
p = 0.02). The Met-allele carriers who tried to regulate their body weight by 
reducing meal frequency or starvation scored higher on Bulimia subscale, i.e., 
they were more engaged in binge eating. In addition, a tendency to consume 
less calories in the food restrictive Met-allele carriers was observed, and this 
was statistically significant among the users of the most severe method, 
starvation (BDNF Val66Met × food restriction interaction on energy intake: 
F(1,391) = 4.16, p = 0.04). The interactions remained significant after the 
covarying effect of BMI was controlled for. There was no Val66Met genotype × 
food restriction interaction effect on Bulimia scores in boys, but bulimic 
behaviour in boys is infrequent. 
Our results show the modulating effect of BDNF Val66Met polymorphism 
on the association between food restriction and binge eating, whereas Met-allele 
carriers are more vulnerable to the effect of food restriction to induce binge 
eating as compared to Val-homozygotes. Met-allele carriers have been reported 
to be more reactive to negative stimuli (Montag, 2008) and score higher on 
reward dependence (Itoh, 2004). The association of poor reward-related 
inhibition response with binge eating has also been shown in eating disorder 
patients (Rosval et al., 2006). It is thus possible that the BDNF Met-allele has a 
role in the development of eating disorders because it increases reward 
dependence, which enhances vulnerability to binge eating in subjects who 
engage in restrictive diets. Interestingly, these results correspond to our findings 
of the effects of BDNF Val66Met polymorphism on Conscientiousness on the 
same sample, assessed at the same time point (Paper I). The Met-allele carriers, 
who we also found more likely to practice binge eating while trying to restrict 
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food intake in Paper IV, scored significantly lower on Conscientiousness. As a 
trait for persistence, organization, self-discipline and orderliness, Conscien-
tiousness has been found to be associated with disordered eating behaviour 
(Ghaderi and Scott, 2000, Podar et al., 1999). In a recent twin study a negative 
correlation between Conscientiousness and binge eating episodes was 
confirmed (Koren et al., 2014). In addition, the authors reported 45% of the 
covariance between Conscientiousness and binge eating to be due to additive 
genetic and 55% individual-specific environmental factors, which may therefore 
suggest shared etiological underpinnings with lack of control during binge 
eating episodes (Koren, 2014).  
 
4.2.2. The effect of COMT Val158Met polymorphism on 
educational attainment, socioeconomic status and history  
of mood disorders (Paper II and unpublished data) 
Personality is considered to be fully developed by the time of young adulthood 
(Costa et al., 1994). Our results indicate that, indeed, the COMT Val158Met 
genotype effects were more evident at age 25, compared to ages 15 and 18. 
Such genotype-dependent development of personality could be expected to have 
an influence on obtaining education, and educational achievements importantly 
shape the environment of the individual (Alvarez-Galvez et al., 2013, Lynch et 
al., 1997). The well-established effects of COMT genotype on the function of 
prefrontal cortex provide further reason to examine its possible impact on 
academic achievements, as both personality and cognitive abilities are of great 
importance in educational attainment. Therefore, in Paper II, we tested if 
COMT Val158Met genotype has an effect on participants’ educational 
attainment by the age 25. 
We found a genotype × gender effect on obtaining education. Males with 
Val/Met genotype had mainly obtained secondary or vocational education, 
whereas female heterozygotes had rather striven for higher education (Figure 6). 
Previously, several authors have reported no effect of COMT genotype on years 
of education or educational attainment (Liu et al., 2008, Martin et al., 2011, 
Sheldrick et al., 2008). One of the reasons for these negative findings could 
however be the structure and recruitment of samples. None of these samples has 
been population-representative, which could result in a bias due to the limited 
variability in the characteristics of study participants. Interestingly, Enoch and 
colleagues (Enoch et al., 2009) reported an interaction between COMT 
genotype and years of education affecting the scores of the Information (verbal 
comprehension and long-term memory) and Block Design (working memory) 
subscales of the WAIS-R. Interestingly, in the less educated group (crossover 
point 11–12 years), Met-allele carriers scored lower than Val homozygotes, 
whereas in the higher educated group Met-allele carriers had markedly better 
scores. According to the authors’ interpretation, the Met-allele carriers need a 
good educational environment in order to develop their full potential for 
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superior cognitive skills compared to Val homozygotes. In case of adversity, 
their emotional vulnerability may deteriorate the development of cognitive 
skills. Thus, our finding that participants with the Val/Met genotype tend to 
have higher Conscientiousness scores than other genotypes is in line with the 
effect of COMT Val158Met genotype on education levels, but the direction of 
causality, if any, remains an open matter. People with high Conscientiousness 
scores are more organized, dutiful and self-disciplined. Therefore, they are more 
likely to be successful in all of their endeavors. However, although participants 
with the Val/Val genotype scored lower on Conscientiousness, in educational 
attainment by age 25, the heterozygotes differ from both of the homozygote 
groups. This effect could be explained with the Met homozygotes’ vulnerability 
to stress and Val homozygotes’ poorer cognitive performance, which both can 
affect the educational attainment. Also different adaptive strategies can play a 
role, heterozygotes possibly developing better coping strategies by the time of 
young adulthood than homozygotes. In addition, these strategies appear to differ 
between genders, which can explain the gender differences in the Val/Met 
group. For example, males with the Val/Met genotype may not have felt the 
pressure to obtain higher education, if there were faster options to success in the 
society. 
 
 
Low socioeconomic status is a strong predictor for a wide range of physical and 
mental health problems (Adler et al., 1994, Andrade et al., 2000, Lynch, 1997), 
and therefore we aimed to study the COMT Val158Met polymorphisms’ effect 
on the monthly income and perceived socioeconomic status of the individual 
and the household. The COMT genotypes did not differ in terms of monthly 
income and monthly income of the household in either gender. Interestingly, 
heterozygote women assessed their socioeconomic status to be higher as 
 
 
Figure 6. Educational levels by genotype and gender. Significantly higher than 
expected female COMT Val158Met Val/Met representation in higher education group, 
and lower representation of males (Chi-square = 13.6; df = 2; p = 0.001). 
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compared to both homozygote groups (F(2,277) = 3.53; p = 0.03). This may be 
related to their level of educational attainment. In addition, they tend to score 
lower on Neuroticism and higher on all other FFM personality traits than all 
remaining genotype groups. As the professional carriers unfold, further follow-
ups may be more informative on whether or not the genotype-related 
differences in education will have an impact on other measures such as income.  
 In females, there was a tendency for Val-homozygotes to perceive their 
economic status of their household to be poorer as compared to both Val/Met 
heterozygotes and Met-homozygotes, although there were no differences in 
reported monthly incomes of the participants or their households. There were no 
differences between genotypes in the perceived socioeconomic status and 
economic status of the household in males. Recently it was confirmed that the 
Val-allele of COMT genotype increased in an allele-dose fashion the amygdala 
activity in response to fearful and angry facial stimuli. The effect was 
demonstrated only in females (Domschke, 2012). All this is in line with the 
notion that people with high Neuroticism experience more often negative affect 
which in turn manifests in negative bias in information processing. 
Dysfunction in the major DA pathway in the brain, the mesolimbic/ 
mesocortical system, is proposed to contribute to the pathophysiology of 
depression (Nestler and Carlezon Jr, 2006). The COMT Val158Met variation is 
indeed found to modulate corticolimbic responses to emotional stimuli 
(Drabant, 2006, Smolka, 2005) and be involved in increased susceptibility to 
depression, stress and anxiety (Drury, 2010, Eley, 2003, Enoch, 2003, Hettema, 
2008, Massat, 2004, Stein, 2005). Hence, we examined the effect of COMT 
polymorphism on the history of anxiety and mood disorders, and on the self-
rated depressiveness (MÅDRS) and anxiety scores (STAI-S and STAI-T). 
 We did not observe any differences in genotype frequencies in individuals 
with anxiety and mood disorders and healthy controls in either gender. 
However, we detected a significant effect of COMT genotype on depressiveness 
at age 25 (F(2, 485) = 4.97, p = 0.007), whereas Val-homozygotes scored higher 
than other genotype groups (Unpublished data) (Figure 7). Regarding self-
rated state and trait anxiety scores, we did not detect any significant genotype 
effects on STAI scores, but a tendency emerged on STAI-T (F(2, 474) = 2.98,  
p = 0.052), again showing the highest scores of the Val-homozygotes. To be 
noted, we did not find any gender differences in genotype effects on 
depressiveness nor anxiety scores. 
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With these results we provide further evidence of Val/Val genotypes’ effect on 
depressiveness. Nevertheless, previous studies have resulted in variable findings 
on depression, anxiety and negative emotionality, as some authors report the 
Met-allele and others the Val-allele to increase the susceptibility risk. One of 
the confounders may regard ethnicity of the subjects, as differences in geno-
typic distributions have been found across ethnic groups (Palmatier et al., 
1999). In Caucasians, the Met-allele has often been associated with Neu-
roticism, but rather appears as decreasing the risk for anxiety and mood 
disorders. The Val-allele has been associated with higher phobic anxiety scale 
scores (McGrath, 2004), early onset of major depressive disorder in Caucasian 
samples (Massat, 2004), and the Met-allele has been found to be protective for 
depressive symptoms in children exposed to early social deprivation (Drury, 
2010). Val/Val genotype has also been found to be more prevalent in suicide 
attempters than in normal controls, whereas in females it had an effect on the 
scores on STAXI (State-Trait Anger Expression Inventory) subscales Trait 
Anger and Anger Control (Baud, 2007). Parenthetically, our results also 
revealed the women with Val/Val genotype to score the highest on Anger 
subscale of the EE.PIP-NEO Neuroticism scale (F(2, 450) = 6.12, p = 0.002). In 
addition, a meta-analysis concluded that the Val-allele is associated with panic 
disorder in Caucasian and Met-allele in Asian samples, and these results were 
restricted only to females (Domschke et al., 2007). Regarding Asians, the Met-
allele has also been associated to higher negative emotionality in females (Chen, 
2011). Hettema and colleagues’ study (Hettema, 2008) based on selected cases 
and controls from a large twin cohort found a haplotype of COMT Val158Met 
Val-allele with the A allele of rs165599 polymorphism to predict both higher 
Neuroticism and risk for anxiety disorders and major depression in a Caucasian 
sample, whereas these effects were again specific to females. Taken together, 
this issue needs further clarification on large ethnically homogeneous samples 
and the role of population differences as potential confounders should be taken 
into account in future meta-analytic studies.  
 
Figure 7. The effect of COMT Val158Met on depressiveness scores at age 25 (+/– SEM). 
* – p < 0.001 vs. all other groups; Fisher’s LSD. 
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4.2.3. Influence of TPH2 G-703T polymorphism on mood and 
anxiety disorder symptoms (Unpublished data) 
Considering the rate-limiting effects of TPH2 on serotonergic neurotrans-
mission, the possible effect of TPH2 gene variants on mood and anxiety 
disorders has been considered. As discussed in the introduction section, the 
TPH2 G-703T polymorphism has been found associated with depression and 
higher amygdala reactivity to emotional stimuli, as well as with emotional 
instability. As described above, our results also indicate the TPH2 G-703T 
effect on the personality traits Neuroticism and Conscientiousness. Thus we 
aimed to investigate the possible association of this gene variation with the 
scores of depressiveness inventories BDI and MÅDRS, as well as trait and state 
anxiety scores (STAI-S and STAI-T). 
Data of depressiveness rating scales were available for both cohorts from the 
second and third study wave. STAI scores were collected from the younger 
cohort during second and third study wave, and only for the third study wave 
for the older cohort.  
We did not find any genotype effect on the scores of depressiveness or 
anxiety rating scales. However, by the age 25, we detected a tendency for a G × G 
interaction effect with 5-HTTLPR genotype on STAI-T (F(4, 468) = 1.99, 
p = 0.095) and STAI-S (F(4, 467) = 1.78, p = 0.132). The TPH2 T/T homozygotes 
with 5-HTTLPR S-allele compared to L/L homozygotes had a tendency of 
scoring lower on both STAI scales. This is in accordance with our findings 
regarding personality traits, where the subjects in the same genotype groups 
were scoring lower on Neuroticism and higher on Conscientiousness. In-
terestingly, by the age 25, we did not find these genotype associations with 
personality traits in older cohort, but instead a tendency towards lower anxiety. 
One of the possible explanations could be more pronounced social desirability 
in personality questionnaire responses by age 25, which may bias the variance 
of the personality scores. Another possible confounder may regard the 
environmental effects in developing psychiatric disorders. Indeed, the impor-
tance of life stress in depression etiology is well known (e.g. Fava and Kendler, 
2000). More specifically, the genotype interactions with the number of stressful 
life events have been repeatedly reported to influence depression risk (Caspi, 
2003, Kendler et al., 2005). Therefore the possible gene × environment effects 
should be addressed in the future.  
Currently, regarding anxiety scales only data of the older cohort at age 25 
are available. Hence, this possible G × G interaction on anxiety scores should be 
investigated again in the near future, when the presently ongoing data collection 
for younger cohort at age 25 has been completed and data of the two cohorts 
can be pooled for statistical analysis. 
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5. CONCLUSIVE REMARKS 
The presence of a notable genetic component in personality development and 
depression etiology is generally well recognized. The rapid biotechnological 
advances are contributing to wider availability of genetic research methods in 
unraveling specific genetic loci underlying the vulnerability of depression and 
negative emotionality. However, regardless of some successes in detecting 
genetic risk variants, a lot still remains unknown.  
With this dissertation, we have contributed in this field of research by 
demonstrating the effects of several depression- and anxiety-related common 
gene variants and gene × gene interactions on personality traits, potential risk 
factors in depression etiology. Furthermore, we show genotype effects on 
additional health-related factors, such as binge eating in body weight regulation, 
educational attainment, perceived socioeconomic status and depressiveness. 
Although the BDNF Val66Met, TPH2 G-703T and 5-HTTLPR poly-
morphisms have repeatedly been associated with Neuroticism and Harm 
Avoidance, interestingly we have found instead the main effects of BDNF 
Val66Met and TPH2 G-703T on Conscientiousness, a trait for discipline, order 
and persistence, which is often linked to psychopathology and memory 
processes. In addition, we observed moderation by the 5-HTTLPR poly-
morphism, whereas subjects with a combination BDNF Val66Met Met-allele 
and 5-HTTLPR S/S genotype scored the lowest in Conscientiousness, but a 
combination of TPH2 G-703T T/T and 5-HTTLPR S-allele yielded the highest 
scores. Genotype effects on Conscientiousness are not frequent findings; 
however this is not surprising considering the common usage of biased samples, 
e.g. university students. Therefore these preliminary results should be replicated 
in the future in unbiased samples. 
We are not aware of any reports on the genotype interaction effects of BDNF 
or TPH2 and 5-HTTLPR on Conscientiousness, but the results are not 
surprising, as such interactions have been found on several other depression-
related phenotypes. As BDNF, TPH2 and 5-HTT are key elements in 
serotonergic neurotransmission, the interaction effects should have been 
expected.  
Another important factor modulating the genotype effects is time, which 
allows the environmental effects and development to take place. Our results 
suggest the relevance of time and maturation in genotype effects on 
Neuroticism, as the effect of COMT Val158Met was most evident by the age 
25; and the effect of TPH2 G-703T was evident at age 15, but not 18. This 
implies the possible role of respective neurotransmitter systems in personality 
development and emphasizes the importance of future studies in longitudinal 
samples, being also compatible with the large difference in genes implicated in 
depression of childhood vs. adulthood (Harro and Kiive, 2011).  
Genotypes under investigation also influenced other aspects of the lives of 
our subjects. The BDNF Val66Met Met-allele carriers, who we found to be with 
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low Conscientiousness, seem to be more engaged in binge eating while 
restricting food intake to regulate body weight. In addition, COMT Val158Met 
Val/Val homozygotes had the highest depressiveness scores and, furthermore, 
females with the Val/Met genotype, less neurotic than both homozygote groups, 
also had more likely pursued higher education by age 25 and assessed their 
socioeconomic status to be better. The subjects with the combination of TPH2 
G-703T T/T and 5-HTTLPR S-allele tended to score lower on anxiety scales by 
the age 25 as compared to the L/L homozygotes of 5-HTTLPR. 
Considering the population representative nature of our sample and 
relatively young age of study participants, the findings of genotype effects on 
diagnostic criteria meeting anxiety and mood disorders would have been 
unlikely and indeed they were not found. Nevertheless, by studying the 
genotype effects on the results of anxiety and mood disorder inventories 
continuously, we could assess the possible risk of developing such disorders. 
Therefore, this issue should be addressed in the future to assess whether this 
possible risk will eventually lead towards a diagnosis of anxiety or mood 
disorder in the general population. 
To conclude, the difficulties in unraveling the genetic foundations of 
personality traits and depression suggest a large number of additional factors, 
which may modulate the emergence of genotype effects. Our work on 
depression- and anxiety-related candidate genes in a large population 
representative sample highlights the significance of considering time, sex and 
gene × gene interactions as possible modulators of genotype effects. Moreover, 
it is important to invest into sample designs which enable to study genotype 
effects on complex behaviour in unbiased manner. 
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SUMMARY IN ESTONIAN 
Depressiooni ja ärevusega seotud geenivariandid: mõju 
isiksuseomadustele ja tervistmõjustavale käitumisele 
Varasemate uuringute põhjal on teada, et mõned isiksuseomadused suurendavad 
depressiooni tekkimise riski. Üheks levinumaks selliseks isiksuseomaduseks 
peetakse Neurootilisust, mis näitab inimese kalduvust liigsele muretsemisele ja 
ärevuse tundmisele. Nii isiksuseomadustel kui ka depressioonil on aga tugev 
pärilik taust, seejuures osa geneetilisest alusest arvatakse neil olevat ühine. Kuid 
hoolimata jõudsatest arengutest biotehnoloogia valdkonnas ei ole siiani 
kummagi fenotüübi geneetilist alust suudetud tuvastada. Olulist rolli mängib 
siin kindlasti asjaolu, et tegemist on väga komplekssete tunnustega, millel on 
tõenäoliselt ka väga keeruline geneetiline taust. 
Käesolevas väitekirjas uurisime suurel rahvastikupõhisel valimil, kuidas 
mõjutavad depressiooniga seotud geenivariandid isiksuseomadusi. Kõik uurimis-
alused geneetilised variandid on seotud aju neurotransmissiooniga - 5-HTTLPR 
ja TPH2 G-703T polümorfismid serotoniini- ja COMT Val158Met dopamiini-
süsteemiga, aga BDNF Val66Met neurotroofiliste funktsioonidega, mis on 
olulised närvirakkude arengu ja funktsionaalsuse tagamisel. Lisaks oli meie 
eesmärgiks teada saada, kas esineb ka nende geenide vahelisi interaktsioone, 
kas vanus mängib rolli ning lisaks, kas nimetatud geenivariandid võivad 
mõjutada ka muid tervise ja heaoluga seotud tegureid, nagu näiteks meeleolu- ja 
söömishäirete sümptomaatika, kõrghariduse omandamine ja sotsiaalmajanduslik 
staatus. 
Leidsime, et kõik nimetatud kandidaatgeenid tõepoolest mõjutavad isiksuse-
omadusi rahvastikus. Täpsemalt, BDNF Val66Met Met-alleeli kandjad on 
madalama, kuid TPH2 G-703T T/T genotüübiga isikud kõrgema Meelekindlu-
sega, võrreldes teiste genotüübi gruppidega. Samas esines mõlema geeni-
variandi puhul ka interaktsioon 5-HTTLPR polümorfismiga, kusjuures 
kummagi genotüübi mõju oli kõige tugevam just 5-HTTLPR S/S 
homosügootide hulgas. TPH2 T/T homosügootidel oli 15-aastaselt ka teistest 
palju madalam Neurootilisus, kuid kolm aastat hiljem oli see erinevus kadunud 
ning genotüübi mõju Neurootilisusele ei olnud. Lisaks leidsime ka COMT 
Val158Met mõju Neurootilisusele – Val/Val genotüübiga naised olid oluliselt 
neurootilisemad kui teiste alleelikombinatsioonidega naised. Huvitaval kombel 
avaldus genotüübi mõju alles 25-aastaselt, mis viitab ajafaktori olulisusele 
genotüübi efekti avaldumisel. 
Edasi uurisime, kas nimetatud geenide mõju isiksusele võiks peegelduda ka 
teistes inimese tervise ja heaoluga seotud tegurites. Esiteks leidsime, et BDNF 
Val66Met polümorfism avaldab mõju ka söömishäirete sümptomaatika tekki-
misel. Nimelt nende tüdrukute seas, kes püüdsid oma kehakaalu reguleerida 
toidukoguste vähendamise või näljutamise teel, esines Met-alleeli kandjail Val-
homosügootidest oluliselt rohkem kontrollimatuid söömishooge, mida peetakse 
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söömishäire buliimia peamiseks sümptomiks. Lisaks leidsime, et COMT geno-
tüübi Val-homosügootidel on kõrgem depressiivsus ja COMT genotüüp näib ka 
mõjutavat inimeste haridusteed. Nimelt 25ndaks eluaastaks oli kõige suurem 
hulk kõrgharidust omandavate inimeste hulk Val/Met naiste seas ning vastu-
pidiselt, kõige vähem, Val/Met meeste seas. Lisaks olid just Val/Met geno-
tüübiga naised need, kes hindasid oma sotsiaalmajanduslikku staatust teistest 
paremaks. Ka ei tuvastanud me TPH2 mõju meeleoluhäiretele, kuid sellegi-
poolest leidsime G × G interaktsiooni tendentsi ärevusele 25-ndaks eluaastaks – 
TPH2 T/T ja 5-HTTLPR S-alleeli kombinatsiooniga isikutel on madalam ärevus 
kui 5-HTTLPR L/L homosügootidel.  
Kokkuvõttes, leidsime neurotransmissiooni mõjutavate geenivariantide mõju 
isiksuseomadustele, Neurootilisusele ja Meelekindlusele, suurel populatsiooni-
põhisel valimil ning lisaks kinnitasime, et need seosed peegelduvad ka teistes 
tervise ja heaoluga seotud tegurites. Käitumisgeneetika valdkonna ummikseis 
isiksuseomaduste, aga ka teiste keeruliste fenotüüpide geneetiliste aluste 
tuvastamisel viitab erinevatele moduleerivatele mõjuteguritele geeniefektide 
avaldumisel. Käesoleva väitekirja tulemuste põhjal rõhutame soo, vanuse ja 
geenidevahelise interaktsiooni arvestamise olulisust genotüüpide mõju uuri-
misel komplekssetele fenotüüpidele. Lisaks pole vähemtähtis, et paljud geno-
tüübi efektid isiksuseomadustele saavad ilmneda vaid suurte ja kallutamata 
valimite uurimisel.  
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